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Synopsis: The copper sulfate, Sahli method, and HemoCue tests were found to be 
accurate tools for the detection of anemia during pregnancy. 
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Abstract 
Background: Anemia is a substantial contributor to poor pregnancy outcomes in 
low- and middle-income countries. Access to laboratory facilities is limited; therefore, 
on-site testing warrants attention. 
Objectives: To determine the accuracy of on-site tests to detect anemia in 
pregnancy. 
Search strategy: MEDLINE, Embase, Scopus, CINAHL, and Web of Science were 
searched from inception until March 2016, with no language restrictions, using the 
terms “pregnancy,” “an(a)emia,” and “h(a)emoglobin.” 
Selection criteria: Studies that evaluated the diagnostic accuracy of on-site 
hemoglobin tests versus laboratory-based reference tests during pregnancy were 
included. 
Data collection and analysis: Study characteristics and true positive, true negative, 
false positive, and false negative rates were extracted. Sensitivity, specificity, 
likelihood ratios, and post-test probabilities were calculated. Anemia was defined as 
a hemoglobin level of less than 110 g/L. 
Main results: Ten studies (4239 participants) were assessed. Copper sulfate 
provided 97% sensitivity (95% confidence interval [CI] 88%–100%) and 71% 
specificity (95% CI 55%–85%); the Sahli method provided 86% sensitivity (95% CI 
75%–94%) and 83% specificity (95% CI 68%–93%); and HemoCue provided 85% 
sensitivity (95% CI 79%–90%) and 80% specificity (95% CI 76%–83%). 
Conclusions: Some on-site tests are accurate and should be made widely available 
to improve detection of anemia in pregnancy. 
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1 INTRODUCTION 
Maternal anemia—defined as a low blood hemoglobin concentration—remains a 
serious global health problem. This condition is detected among 42% of all women 
during pregnancy; Africa and Southeast Asia are the most affected geographic 
regions [1,2]. An estimated 56 million pregnant women have anemia; furthermore, 
the rate of this condition has declined by only 5% since 1995 [1]. 
 
Anemia is the most frequent indirect cause of adverse maternal outcomes and 
mortality, contributing to up to 50% of both [3]. The risks of macerated late fetal 
death, fresh late fetal death, and early neonatal death are consistently increased 
among mothers with severe anemia [4]. A link has also been found between anemia 
and low birth weight, small for gestational age, and preterm birth [2,5]. Furthermore, 
women with anemia are less likely to overcome the adverse effects of excessive 
blood loss and are more susceptible to infection, fatigue, and depression than are 
women without this disorder [6]. 
 
Testing for anemia is done infrequently and with low accuracy in low-income and 
middle-income countries (LIMICs), especially in rural locations. In this setting, 
anemia can go undetected because diagnosis is often based on symptoms and 
physical examination rather than on objective testing [7]. Laboratory measurement of 
cyanmethemoglobin by spectrometry is the gold standard, but use of this test is 
hampered by high cost and low availability [8]. Consequently, simple, safe, accurate, 
and low-cost hemoglobin assessment tools were introduced to address this issue [9]. 
On-site testing to detect anemia is a potential option to increase accessibility. 
Methods currently in use include HemoCue (HemoCue, Ängelholm, Sweden), WHO 
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hemoglobin color scale (HCS), and copper sulfate; however, their diagnostic 
accuracy is not well characterized. 
 
Systematic reviews have been published on the accuracy of HCS, HemoCue, and 
non-invasive methods but they did not include studies exclusively conducted in a 
prenatal care setting [10,11]. The threshold used to diagnose anemia in pregnancy 
differs from that of a nonpregnant population [12]. Previous reviews have included a 
mixed population, which is a key deficiency because disease spectrum variation has 
an impact on accuracy [13,14]. Reviews have also used HemoCue as a reference 
test [11] because it is more widely available than the gold-standard laboratory test in 
low-income countries. Nonetheless, measurement of hemoglobin concentration by 
HemoCue provides lower precision than that of automated analyzers, and its 
precision also varies by sample type (i.e. whether the sample is taken from a 
capillary or vein) [15–17]. 
 
Therefore, the aim of the current systematic review was to determine the accuracy of 
on-site tests to detect anemia among pregnant women in LIMICs. 
 
2 MATERIALS AND METHODS 
A systematic review of on-site testing for maternal anemia was conducted in line with 
current recommendations. The protocol was registered with the PROSPERO 
international prospective register of systematic reviews (CRD42015029172), and 
methods of data reporting adhered to the Preferred Reporting Items for Systematic 
Reviews and Meta-analyses guidelines [18]. 
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2.1 Literature search 
The MEDLINE, Embase, Scopus, CINAHL, and Web of Science databases were 
searched for relevant studies from inception until March 21, 2016. No language 
restrictions were imposed on the literature search. Medical subject headings, text 
words, and word variants for "pregnancy" were combined with the terms "an(a)emia" 
and "h(a)emoglobin," with exclusion (“NOT”) of words relating to the fetus such as 
“cord,” “neonatal,” and “placenta” (Appendix S1). The reference lists of the included 
studies and relevant reviews were searched for additional eligible studies. 
 
2.2 Study selection 
A two-stage process was used to select studies for inclusion in the present 
systematic review. First, the titles and abstracts of all citations were screened for 
potential relevance. Second, SS and ER independently examined the full text of the 
retrieved papers using prespecified inclusion criteria; discrepancies were resolved by 
discussion with KSK. The inclusion criteria were recruitment of pregnant women 
attending prenatal care, comparison of any on-site test for hemoglobin concentration 
with a laboratory-based reference test, and provision of diagnostic accuracy data. 
Case–control studies, prevalence studies, and studies that enrolled non-pregnant 
populations were excluded. 
 
2.3 Data extraction and quality assessment 
Data extraction and assessment of study quality were performed by SS and ER, with 
discrepancies resolved following input from KSK. Data were extracted using a 
standardised pre-piloted form. Information on the type of test, setting, sample 
(venous or capillary blood), and the type of practitioner who conducted the tests was 
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included. Data were extracted for different thresholds of hemoglobin concentration 
as per WHO standards [12]. Anemia in pregnancy was defined as a hemoglobin 
concentration below 110 g/L at sea level and categorized as mild (100–109 g/L), 
moderate (70–99 g/L), or severe (<70 g/L). True positive, true negative, false 
positive, and false negative rates were extracted for the reference and index tests in 
a 2×2 contingency table. The parameters required to assess accuracy were 
recalculated in cases for which the sensitivity, specificity, positive predictive values, 
and negative predictive values were presented. 
 
Study quality was assessed independently by SS and ER using the QUADAS-2 tool 
[14]. Four domains were evaluated: patient selection, use of the index test, 
implementation of the reference standard, and timing of the index test(s) and 
reference standard (“flow and timing”). Risk of bias (low, high, or unclear) and 
concerns about applicability of the findings were assessed for these domains. A 
high-quality study was one that had consecutive or randomized patient selection, 
had specific inclusion and exclusion criteria, and used recognized index and 
reference (gold-standard) tests that were performed with an appropriate delay 
between them. 
 
2.4 Data analysis 
The data were analyzed using STATA version 12.1 (Stata, College Station, TX, 
USA). True positive, false positive, true negative, and false negative rates were 
obtained from the publication or, if necessary, calculated from the reported estimates. 
The data were plotted in the receiver operating characteristic (ROC) space. When a 
sufficient number of studies was available, the diagnostic accuracy parameters were 
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pooled using a bivariate random-effect hierarchical model [19]. If fewer than four 
studies reported accuracy of a given test, the sensitivity, specificity, and likelihood 
ratio were pooled using a univariate model [20]. The 95% confidence interval (CI) 
was calculated for all estimates to indicate precision of test accuracy. Assuming a 
pre-test probability of 42% for a hemoglobin concentration of less than 110g/L [2,21], 
post-test probabilities for a negative and positive test result were calculated using an 
online calculator [22]. A pretest probability of 8% and 1% was used for moderate and 
severe anemia, respectively [21]. 
 
3 RESULTS 
The selection process for the 10 studies included in the present systematic review is 
outlined in Figure 1. As shown in Table 1, these studies included 4239 pregnant 
women from seven LIMICs: India (n=2), South Africa (n=2), Sri Lanka (n=2), Benin 
(n=1), Kenya (n=1), Malawi (n=1), and Pakistan (n=1). Six index tests were identified 
and compared with a laboratory reference test. Five studies reported data on clinical 
examination [25–27,29,30], four on HCS [25,28–30], and three on the copper sulfate 
test [23,24,31]. HemoCue [25], the Sahli method [31], and a non-invasive 
hemoglobin sensor (NBM 2000) [32] were each reported in one study. The studies 
were published between 1996 and 2016. The prevalence of anemia (hemoglobin 
<110 g/L [12]) across the 10 studies was 23%–77%. 
 
Quality assessment indicated that five (50%) of the studies had low risk of bias and 
low concern regarding applicability across all domains (Table 2). One (10%) study 
had a high risk of bias regarding patient selection. Three (30%) studies had an 
unclear risk of bias because the recruitment process was not adequately described. 
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One (10%) study had an unclear risk of bias regarding flow and timing. All studies 
had low risk of bias for applicability. 
 
Accuracy of the on-site tests is outlined in Table 3. Seven studies provided 
diagnostic accuracy data for mild anemia (hemoglobin <110 g/L) [25,27–32]. 
Sensitivity ranged from 97% (copper sulfate) to 34% (NBM 2000). By contrast, 
specificity ranged from 92% (NBM 2000) to 62% (clinical assessment). Three studies 
also provided diagnostic accuracy data for mild anemia defined as hemoglobin 
<100 g/L [23–25]. Copper sulfate had 96% sensitivity (95% CI 89%–100%) and 89% 
specificity (95% CI 72%–99%); HemoCue had 94% sensitivity (95% CI 90%–97%) 
and 79% specificity (95% CI 75%–83%); HCS had 82% sensitivity (95% CI 76%–
86%) and 45% specificity (95% CI 41%–50%); and clinical assessment had 73% 
sensitivity (95% CI 70%–76%) and 80% specificity (95% CI 77%–84%). 
 
A general overview of the ROC data is shown in Figure 2, whereas ROC data for 
clinical assessment and HCS are shown in Figures S1 and S2, respectively. 
 
Table S1 shows the data for moderate anemia (hemoglobin <80 g/L). One study [25] 
provided diagnostic accuracy data for three tests: clinical assessment (644 women), 
HCS (641 women), and HemoCue (671 women). Another study [31] provided data 
for copper sulfate (100 women) and the Sahli method (100 women) with a cutoff 
hemoglobin level of less than 88 g/L. HemoCue had 97% sensitivity (95% CI 85%–
99%) and 94% specificity (95% CI 92%–96%); the Sahli method had 83% sensitivity 
(95% CI 85%–98%) and 93% specificity (95% CI 85%–98%); HCS had 82% 
sensitivity (95% CI 61%–93%) and 76% specificity (95% CI 73%–79%); copper 
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sulfate had 75% sensitivity (95% CI 55%–89%) and 94% specificity (95% CI 86%–
98%); and clinical assessment had 62% sensitivity (95% CI 44%–77%) and 76% 
specificity (95% CI 72%–78%). 
 
Data for severe anemia are also presented in Table S1. One study [25] defined 
severe anemia as a hemoglobin level of less than 60 g/L and provided accuracy data 
for three tests: clinical assessment (644 women), HCS (641 women), and HemoCue 
(671 women). Another study [31] defined severe anemia as a hemoglobin level of 
less than 66 g/L and provided accuracy data for copper sulfate (100 women) and the 
Sahli method (100 women). HemoCue had 83% sensitivity (95% CI 44%–97%) and 
99% specificity (95% CI 98%–100%); the Sahli method had 75% sensitivity (95% CI 
35%–97%) and 93% specificity (95% CI 86%–98%); copper sulfate had 63% 
sensitivity (95% CI 24%–91%) and 93% specificity (95% CI 86%–98%); HCS had 
50% sensitivity (95% CI 15%–85%) and 98% specificity (95% CI 97%–99%); and 
clinical assessment had 50% sensitivity (95% CI 15%–85%) and 75% specificity 
(95% CI 71%–78%). 
 
4 DISCUSSION 
The present review assessed the accuracy of on-site tests to detect anemia in 
pregnancy. Copper sulfate, the Sahli method, and HemoCue had the highest 
sensitivities (≥85%). Furthermore, each of these methods performed better than did 
clinical assessment alone. Strengths of the present review included use of a 
systematic protocol. The analysis included studies of predominantly high quality that 
covered a wide range of tests and enrolled women with a range of anemia severity, 
which allowed generalization across the spectrum of the disease. 
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Cyanmethemoglobin spectrophotometry is the global reference standard for 
detecting hemoglobin concentration [8]. A limitation of the present review was that it 
included studies that used any laboratory test as a reference standard, such as 
automated cell counters. Although these machines are calibrated against the 
reference standard, this calibration could have affected the accuracy of the test. 
 
A univariate model was used to pool sensitivity and specificity estimates when fewer 
than four studies were available to compare the accuracy of the identified tests. 
Unlike a bivariate model, this approach did not account for the correlation between 
variables; however, estimates obtained using both models are reported to be similar 
[33]. Other limitations include the fact that only a small number of women had severe 
anemia; therefore, the accuracy of the data at this level might be unreliable.  
 
Post-test probabilities for all evaluated tests were calculated assuming a 42% 
prevalence for anemia (hemoglobin <110g/L) [2]. After the test, among women who 
tested negative using the copper sulfate method, the prevalence of women who did 
not have anemia was reduced to 4%. Using the Sahli method or HemoCue, this 
probability was reduced to 11% and 12%, respectively. The HCS method performed 
poorly and only marginally better (reduction to 27%) than clinical examination alone 
(reduction to 29%). Reviews and studies have recommended the use of the HCS 
[11,30]; however, in the present review, this test had a high likelihood ratio for a 
negative test result, suggesting it might not be as clinically useful as previously 
reported. Additional training could increase its accuracy in a clinical setting because 
HCS performs well under laboratory conditions [34]. The non-invasive hemoglobin 
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probe NMB 2000 had low sensitivity but high specificity, which suggested that this 
test could be indicative of the presence of anemia in the context of screening. 
 
In LIMICs, where resources are limited, many factors prevent the use of 
technologically advanced equipment, especially at a primary healthcare level [35]. 
Healthcare workers, therefore, need a simple, cheap, and robust device for 
measuring hemoglobin concentration [35]; nonetheless, this approach should not be 
at the expense of accuracy. Choosing the best test to use depends on factors such 
as cost, resources required, the setting in which it will be used, the skills of the 
healthcare workers, and ease of use. Therefore, the choice should probably be 
made at the local level. The HemoCue method is the most expensive test in terms of 
raw materials; however, the cost of training, procurement, and maintenance must 
also be considered. Taking the cost of the test in a resource-poor setting into 
account in combination with accuracy is also important. 
 
A test should have high sensitivity if screening for anemia is used to decide which 
patients should be referred for further investigation and treatment. It is important not 
to miss women with severe anemia because this condition can have substantial 
clinical implications for both the mother and her offspring. Anemia has been linked 
with maternal mortality, increased risk of postpartum hemorrhage, sepsis, risk of 
intrauterine growth restriction, and preterm delivery [3,5]. The first step to reducing 
these risks would be identification of anemia so that the necessary treatment and 
monitoring can be initiated. 
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Increasing test sensitivity usually results in a concomitant reduction in specificity [36]. 
Using a test with high sensitivity but low specificity leads to unnecessary referrals for 
further investigation and so adds to costs for the health service [26]. However, 
clinical implications of test results also play a part. The consequence of missing a 
truly anemic pregnant woman has more severe clinical implications than does 
overtreatment. Most anemia cases that occur in pregnancy are secondary to iron 
deficiency; mild-to-moderate cases can be treated with iron tablets, which tend to be 
well tolerated [37]. For severe anemia, treatment-associated risk is increased 
because it might involve complex interventions such as blood transfusions. The 
adverse effects of these interventions can be serious (e.g. the spread of blood-borne 
disease) [38]. Testing is also important to monitor the effects of any intervention after 
the diagnosis is established, as well as for planning overall management of the 
affected woman, including place of delivery. 
 
Additional research must be done on this topic: there were few studies available for 
inclusion in the present systematic review. It would also be interesting to evaluate 
novel non-invasive tests, especially those using readily available technology such as 
mobile phones [39]. Many studies have assessed devices for the detection of 
anemia; however, these investigations reported correlation coefficients that might be 
misleading and are less clinically useful than sensitivity and specificity. Reporting 
different measures can also limit the ability to perform meta-analysis. Future primary 
studies should be encouraged to report clinically useful accuracy variables. 
Furthermore, a detailed cost analysis of the accurate tests identified in the present 
study would be beneficial. 
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In conclusion, current reliance on clinical examination in LIMICs should be reduced, 
with the availability of accurate on-site tests increased, to help to improve the 
detection of anemia during pregnancy. 
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Figure legends 
Figure 1 Study selection process. 
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Figure 2 Receiver operating characteristic curve of on-site test accuracy 
to detect mild anemia during pregnancy. Mild anemia was defined as a 
Hb level of either less than 110 g/L or less than 100 g/L. Abbreviations: 
Hb, hemoglobin; HCS, hemoglobin color scale. 
 
Supporting information legends 
Appendix S1 Search history for the systematic review. The same search was used 
in all databases. 
 
Figure S1 Receiver operating characteristic curve of the accuracy of clinical signs to 
detect mild anemia (hemoglobin level <110 g/L) during pregnancy. 
 
Figure S2 Receiver operating characteristic curve of the accuracy of hemoglobin 
color scale to detect mild anemia (hemoglobin level <110 g/L) during pregnancy. 
 
Table S1 Accuracy of on-site tests used to diagnose anemia in pregnancy. 
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Table 1 Characteristics of accuracy studies for tests to detect anemia during pregnancy. 
Study Country and setting No. of 
pregnant 
women 
included 
Index test Reference test 
Pistorius 
et al. 1996 
[23] 
Pretoria, South Africa 
Public hospital 
100 CuSO4 Coulter counter 
Wilkinson 
and Sach 
1997 [24] 
Kwala Zulu, South Africa 
One mobile clinic team serving 
14 clinic points across the district 
449 CuSO4 Sysmex analyzer 
van den 
Broek et 
al. 1999 
[25] 
Malawi 
Three rural hospitals and two 
health centers 
644 Clinical 
signs, 
HCS, and 
HemoCue 
Coulter counter 
Shulman 
et al. 2001 
[26] 
Mombasa, Kenya 
District hospital 
1787 Clinical 
signs 
Coulter counter 
Fourn and 
Salami 
2004 [27] 
Benin 
Rural maternity clinic 
480 Clinical 
signs 
Spectrophotometry 
laboratory test 
Prathapan 
et al. 2011 
[28] 
Colombo district, Sri Lanka 
Field prenatal clinics in 11 of 13 
Ministry of Health areas in this 
district 
101 HCS Spectrophotometry 
Laboratory test 
Chathurani 
et al. 2012 
[29] 
Anuradhapura district, Sri Lanka 
Ministry of Health field clinics in 
this district 
115 Clinical 
signs and 
HCS 
Cyanmethemoglobin 
method 
Khan et al. 
2015 [30] 
Karachi, Pakistan 
Community-based prenatal 
clinics in the towns of Gadap, Bin 
Qasim, Kemari, and New Karachi 
194 Clinical 
signs and 
HCS 
Calorimeteric 
hemoglobinometry 
Agnihotri 
et al. 2015 
[31] 
India 
Prenatal clinic in the Obstetrics 
and Gynecology department 
Jawaharlal Nehru Medical 
College 
100 Sahli 
method 
and CuSO4 
Cyanmethemoglobin 
method 
Ahankari 
et al. 2016 
[32] 
India 
Villages in Tuljapur and Lohara 
blocks of Osmanabad district, 
Maharashtra (n=33). 
269 Non-
invasive 
hemoglobin 
sensor 
(NBM 
2000) 
Sysmex analyzer 
XP-100 
Abbreviations: CuSO4, copper sulfate; HCS, hemoglobin color scale. 
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Table 2 Risk of bias of accuracy studies for tests to detect anemia during pregnancy.
a
 
Study Risk of bias Applicability concerns 
Patient 
selection 
Index 
test 
Reference 
standard 
Flow 
and 
timing 
Patient 
selection 
Index 
test 
Reference 
standard 
Pistorius et al. 1996 
[23] 
Low Low Low Low Low Low Low 
Wilkinson and Sach 
1997 [24] 
Low Low Low Low Low Low Low 
van den Broek et al. 
1999 [25] 
Unclear Low Low Low Low Low Low 
Shulman et al. 2001 
[26] 
Low Low Low Low Low Low Low 
Fourn and Salami 
2004 [27] 
Low Low Low Low Low Low Low 
Chathurani et al. 
2012 [29] 
High High Low Low Low Low Low 
Prapathan et al. 
2011 [28] 
Low High Low Low Low Low Low 
Khan et al. 2015 [30] Low Low Low Low Low Low Low 
Agnihotri et al. 2015 
[31] 
Unclear Low Low Unclear Low Low Low 
Ahankari et al. 2016 
[32] 
Unclear Low Low Low Low Low Low 
a
 Risk of bias was measured using the QUADAS-2 quality assessment tool [14] and defined as low, 
high, or unclear. 
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Table 3 Accuracy of on-site tests to diagnose mild anemia during pregnancy.
a,b
 
Index test Prevalence, 
% 
No. of 
studies 
No. of 
women 
Sensitivity, % Specificity, % Likelihood ratio (95% CI) Post-test probability, % 
Positive test 
result 
Negative test 
result 
Positive test 
result 
Negative test 
result 
Clinical 47 (27–72) 4 1853 56 (19–92) 62 (30–93) 1.7 (1.0–2.9) 0.57 (0.33–1.03) 55 29 
HCS 42 (17–67) 4 1051 67 (56–76) 67 (48–82) 2.0 (1.3–3.1) 0.50 (0.40–0.62) 59 27 
CuSO4 58 (48–67) 1 100 97 (88–100) 71 (55–85) 3.4 (2.1–5.5) 0.05 (0.01–0.19) 71 3.5 
Sahli method 58 (48–67) 1 100 86 (75–94) 83 (68–93) 5.2 (2.6–10.3) 0.17 (0.09–0.32) 79 11 
Non-invasive 
hemoglobin 
sensor (NBM 
2000) 
77 (72–82) 1 269 34 (27–41) 92 (82–97) 4.1 (1.7–9.7) 0.72 (0.64–0.82) 75 34 
HemoCue 23 (20–27) 1 671 85 (79–90) 80 (76–83) 4.3 (3.5–5.1) 0.18 (0.12–0.27) 76 12 
Abbreviations: HCS, hemoglobin color scale; CuSO4, copper sulfate. 
a
 The pretest probability for mild anemia (hemoglobin <110 g/L) was 42%. 
b
 Values in parentheses are 95% confidence intervals.
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Full-text review (n=40) 
 
 
 
 
 
 
  
Identified studies (n=7779) 
Electronic databases (n=7766) 
References and other sources 
(n=13) 
Included in systematic review 
(n=10) 
Clinical assessment (n=4) 
Hemoglobin color scale (n=4) 
Copper sulfate (n=3) 
Sahli method (n=1) 
HemoCue (n=1) 
NBM 2000 (n=1) 
 
 
Excluded (n=30) 
Conference abstracts 
(n=2) 
Technical performance 
reviews (n=4) 
Inappropriate populations 
(n=4) 
Prevalence studies (n=3) 
Inappropriate gold 
standards (n=6) 
Diagnostic accuracy data 
not included (n=11) 
Excluded (n=7739) 
Duplicates (n=1580) 
Exclusion criteria (n=6159) 
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